Le Lézard
Classified in: Health
Subject: CCA

Hansa Biopharma to Host Conference Call to Provide Year-End report 2019 and Business Update


LUND, Sweden, Jan. 22, 2020 /PRNewswire/ -- Hansa Biopharma will publish its Year-End report 2019 at 8:00 a.m. CET on February 6, 2020. All interested parties are invited to participate in a telephone conference, which will include a presentation of the interim results and a business update, on the same date at 2:00 p.m. CET. The event will be hosted by Hansa Biopharma's CEO, Søren Tulstrup, and CFO, Donato Spota, and the presentation will be held in English.

Slides used in the presentation will be live on the company website during the call under "Events & Webcast," and will also be made available online after the call. To participate in the telephone conference, please use the dial-in details provided below:

Dial-in numbers for participants:

SE: +46-8-50-55-83-56 
UK: +44-333-30-09-260 
US: +1-833-82-30-586

For additional international numbers, please refer to the complete list on website.

The webcast will be available on hansa.eventcdn.net/2019fy/

For further information, please contact:

Klaus Sindahl, Head of Investor Relations
Hansa Biopharma 
Mobile: +46(0)709-298 269
E-mail: [email protected] 

Rolf Gulliksen, Head of Corporate Communications
Hansa Biopharma 
Mobile: +46(0)733-328 634
E-mail: [email protected]

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/hansa-biopharma-ab/r/hansa-biopharma-to-host-conference-call-to-provide-year-end-report-2019-and-business-update,c3013441

The following files are available for download:

https://mb.cision.com/Main/1219/3013441/1177164.pdf

Hansa Biopharma to host conference call to provide Year-End report 2019 and Business Update

SOURCE Hansa Biopharma AB


These press releases may also interest you

at 16:45
Halozyme Therapeutics, Inc. ("Halozyme") today announced the election of Mahesh Krishnan, M.D. to its Board of Directors. Dr. Krishnan has more than 20 years of experience in healthcare, biotechnology and health services. "Mahesh is a dynamic and...

at 16:35
Geron Corporation , a late-stage clinical biopharmaceutical company, today announced that it will release its first quarter 2024 financial results and business highlights before the market opens on Thursday, May 2, 2024 via press release, which will...

at 16:35
Tilray Brands, Inc. , a leader in the craft beer and cannabis-lifestyle industries, celebrates high honors and awards at the 2024 Craft Brewer's Conference and World Beer Cup. 10 Barrel Brewing won four craft beer awards and 10...

at 16:34
Fusion Pharmaceuticals Inc. , a clinical-stage oncology company focused on developing next-generation radioconjucates (RCs) as precision medicines, today announced that it has filed and is in the process of mailing the management information circular...

at 16:30
In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health Services announced that it will have a Humira® biosimilar available for $0 out of pocket for eligible...

at 16:28
Dr. Siva Mohan, Co-Founder and Chief Medical Officer of RazorMetrics, an Austin-based drug cost reduction platform, is the Best Entrepreneur - Health Products & Services Status: Silver Stevie Winner from the American Business Awards. The Stevie®...



News published on and distributed by: